Table 1

Patient characteristics

Baseline characteristicsControl group (N=82)Exercise group (N=16)P-value
Male sex, n (%)53 (64.6)11 (68.8)0.75
Age (years)64.8±10.564.6±10.60.96
Height (cm)174.3±10.5176.4±8.80.45
Weight (kg)82.4±15.382.8±14.20.92
BMI (kg/m2)27.0±3.826.6±4.30.71
Smoking, n (%)0.58
Yes25 (30.5)3 (18.8)
 Packyears30.0 [13.1–35.6)37.5 (12.5--)
No, stopped31 (37.8)6 (37.5)
 Packyears11.2 [7.5–35.0)10.2 [1.2–40.5)
No, never26 (31.7)7 (43.8)
 Alcohol, n (%)47 (57.3)10 (62.5)0.7
Amount (units/week)3.0 [1.0–6.0)4.0 [1.8–6.3)0.7
Medical historyControl group (N=82)Exercise group (N=16)P-value
Hypertension, n (%)33 (40.2)7 (43.8)0.75
Dyslipidaemia, n (%)21 (25.9)3 (18.8)0.75
Diabetes mellitus, n (%)N/A
 Type I0 (0)0 (0)
 Type II10 (12.2)0 (0)
Rheumatoid arthritis, n (%)4 (4.9)1 (6.3)1
Prior MI, n (%)13 (15.9)3 (18.8)0.72
Prior resuscitation, n (%)1 (1.2)0 (0)1
Heart valve disease, n (%)3 (3.7)1 (6.3)0.52
LVEF*, n (%)N/A
 Normal—good (LVEF>50%)2/2 (100)0/0 (0)
 Mildly reduced (LVEF 40–50%)0/2 (0)0/0 (0)
 Moderately reduced (LVEF 30–40%)0/2 (0)0/0 (0)
 Severely reduced (LVEF<30%)0/2 (0)0/0 (0)
Kidney failure,† n (%)4 (4.9)0 (0)1
 G3a2 (50)
 G3b2 (50)
Cancer, n (%)0.85
Yes, in the past 5 years6 (7.3)2 (12.5)
Yes, not in the past 5 years7 (8.5)1 (6.3)
  • *Left ventricular ejection fraction (LVEF) provides an estimation of the left ventricular function and is measured with a transthoracic ultrasound. Not all patients receive an ultrasound, therefore the number is shown per the number of measured patients.

  • †Kidney failure stages: G1, G2: normal or mildly decreased; G3a: mildly to moderately decreased; G3b: moderately tot severely decreased; G4: severely decreased; G5: kidney failure.

  • BMI, Body Mass Index.